Drug intelligence / Profile preview

growth differentiation factor-6

Development stage
Preclinical
Lead developer
NuVasive
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intradiscal, Intramuscular
01

Overview

Growth differentiation factor-6 (GDF-6), also known as bone morphogenetic protein 13 (BMP-13), is a member of the transforming growth factor-beta (TGF-β) superfamily and the BMP subfamily. It plays a critical role in the development and maintenance of the skeletal system, particularly in the formation of joints, tendons, and the intervertebral disc (IVD). GDF-6 functions by binding to specific BMP receptors, primarily BMPR1B, thereby activating the Smad signaling pathway to regulate the expression of genes involved in extracellular matrix production, such as aggrecan and type II collagen. In therapeutic contexts, recombinant GDF-6 is being investigated for its potential to treat intervertebral disc degeneration (IDD) by promoting disc regeneration, inhibiting pro-inflammatory cytokines (like TNF-α and IL-1β), and alleviating discogenic pain. It is also utilized in regenerative medicine to induce the tenogenic differentiation of mesenchymal stem cells for tendon repair, such as in Achilles tendon injuries.

Other names
Growth differentiation factor 6Bone morphogenetic protein 13Cartilage-derived morphogenetic protein 2rhGDF-6rhGDF6rhGDF 6
02

Targets

BMPR1ABMPR1BBMPR2 (Bone morphogenetic protein receptor type II)ACTR2 (ARP2 / ACTR2)

Beyond the preview

Go deeper on growth differentiation factor-6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on growth differentiation factor-6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call